DICLOFENAC SODIUM TOPICAL

DICLOFENAC SODIUM TOPICAL was reported 36342 times

DICLOFENAC SODIUM TOPICAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 899 0.7135
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 472 0.7066
2 SWOLLEN JOINT COUNT INCREASED 2089 0.6544
3 HEPATIC ENZYME 95 0.6376
4 RHEUMATIC FEVER 2842 0.6369
5 GRIP STRENGTH 145 0.6332
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1264 0.6311
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4083 0.5693
8 C-REACTIVE PROTEIN 520 0.5609
9 FACET JOINT SYNDROME 1707 0.5238
10 DUODENAL ULCER PERFORATION 3832 0.5148
11 RHEUMATOID FACTOR POSITIVE 2968 0.5133
12 SWOLLEN JOINT COUNT 128 0.5120
13 HYPOCHOLESTEROLAEMIA 171 0.4844
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 991 0.4778
15 PEMPHIGUS 5834 0.4662
16 DISLOCATION OF VERTEBRA 1009 0.4420
17 RETINITIS 761 0.4401
18 X-RAY ABNORMAL 745 0.4162
19 HAND DEFORMITY 5361 0.4083
20 HELICOBACTER INFECTION 3799 0.3693
21 SERONEGATIVE ARTHRITIS 374 0.3264
22 MUSCLE INJURY 2704 0.3260
23 PERIPHERAL VENOUS DISEASE 1331 0.3256
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 34 0.3238
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 178 0.3173
26 FOLLICULITIS 3219 0.3067
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1784 0.2744
28 PERICARDITIS 4585 0.2726
29 GLOSSODYNIA 5878 0.2623
30 SYNOVITIS 4715 0.2612
31 C-REACTIVE PROTEIN ABNORMAL 1639 0.2553
32 INSPIRATORY CAPACITY DECREASED 66 0.2383
33 PORPHYRIA ACUTE 337 0.2348
34 BREAST CANCER STAGE III 1429 0.2204
35 LYMPHATIC FISTULA 22 0.2200
36 BONE EROSION 717 0.2025
37 LIP DRY 1758 0.1934
38 WOUND 5276 0.1886
39 GRIP STRENGTH DECREASED 1614 0.1832
40 ANALGESIC DRUG LEVEL ABOVE THERAPEUTIC 26 0.1769
41 BURSITIS 2087 0.1718
42 SYSTEMIC LUPUS ERYTHEMATOSUS 6004 0.1690
43 EMBOLIA CUTIS MEDICAMENTOSA 127 0.1595
44 JOINT RANGE OF MOTION DECREASED 2135 0.1590
45 DRUG TOLERANCE DECREASED 445 0.1583
46 HYPERCHOLESTEROLAEMIA 1521 0.1574
47 WOUND INFECTION 1715 0.1564
48 ONYCHOMADESIS 649 0.1545
49 CONTRAINDICATED PRODUCT ADMINISTERED 4485 0.1480
50 LIVE BIRTH 1229 0.1468
51 IRRITABLE BOWEL SYNDROME 3022 0.1408
52 BLEPHAROSPASM 840 0.1333
53 AUTOIMMUNE DISORDER 1275 0.1307
54 MUSCULOSKELETAL DEFORMITY 30 0.1282
55 ONYCHOMYCOSIS 553 0.1259
56 TEMPERATURE REGULATION DISORDER 273 0.1224
57 LIVER INJURY 2937 0.1195
58 DEATH NEONATAL 166 0.1193
59 FIBROMYALGIA 2851 0.1172
60 OVERLAP SYNDROME 82 0.1171
61 FINGER DEFORMITY 564 0.1163
62 NAIL DISORDER 926 0.1057
63 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
64 JOINT DESTRUCTION 154 0.0990
65 TYPE 2 DIABETES MELLITUS 3307 0.0981
66 MATERNAL EXPOSURE TIMING UNSPECIFIED 363 0.0965
67 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 25 0.0965
68 ARTHROPATHY 5349 0.0961
69 IMPAIRED HEALING 3138 0.0955
70 NAIL OPERATION 39 0.0942
71 PRESCRIBED OVERDOSE 1799 0.0929
72 OBESITY 1435 0.0900
73 PRODUCT LABEL CONFUSION 523 0.0896
74 SCIATICA 1414 0.0886
75 PSORIATIC ARTHROPATHY 3533 0.0870
76 COELIAC DISEASE 847 0.0863
77 INTESTINAL DIAPHRAGM DISEASE 24 0.0860
78 EXOSTOSIS 782 0.0855
79 WRIST DEFORMITY 50 0.0813
80 COLONIC STENOSIS 27 0.0785
81 HIP ARTHROPLASTY 1170 0.0763
82 INFUSION RELATED REACTION 5044 0.0760
83 LUPUS-LIKE SYNDROME 682 0.0751
84 RED BLOOD CELL SEDIMENTATION RATE INCREASED 805 0.0727
85 PULMONARY FIBROSIS 1394 0.0726
86 LOWER LIMB FRACTURE 1378 0.0716
87 WALKING AID USER 470 0.0712
88 HEPATIC ENZYME INCREASED 4812 0.0705
89 DISCOMFORT 4256 0.0697
90 BLOOD CHOLESTEROL INCREASED 3186 0.0683
91 BACK INJURY 719 0.0660
92 DUCTUS ARTERIOSUS STENOSIS FOETAL 27 0.0634
93 BREAST CANCER STAGE II 526 0.0632
94 FOOT DEFORMITY 688 0.0620
95 THERAPEUTIC PRODUCT EFFECT DECREASED 2764 0.0616
96 SPONDYLITIS 222 0.0610
97 LOWER RESPIRATORY TRACT INFECTION 2774 0.0609
98 BLISTER 3331 0.0593
99 SWELLING 5551 0.0593
100 GAIT INABILITY 1965 0.0587
101 ULCER HAEMORRHAGE 395 0.0583
102 RHEUMATOID ARTHRITIS 6538 0.0575
103 JOINT DISLOCATION 606 0.0573
104 INFUSION SITE REACTION 171 0.0572
105 EYE INJURY 173 0.0569
106 FOETAL DEATH 291 0.0561
107 PRESCRIBED UNDERDOSE 1096 0.0549
108 KNEE ARTHROPLASTY 1135 0.0539
109 PUSTULAR PSORIASIS 180 0.0524
110 FOOD ALLERGY 399 0.0516
111 OSTEOARTHRITIS 2150 0.0507
112 MATERNAL EXPOSURE DURING PREGNANCY 4431 0.0497
113 NIGHT SWEATS 1596 0.0495
114 CONGENITAL ANOMALY 372 0.0480
115 DRUG INTOLERANCE 4531 0.0469
116 STOMATITIS 2843 0.0468
117 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 107 0.0464
118 PERFUME SENSITIVITY 26 0.0457
119 JOINT SWELLING 5389 0.0446
120 MOBILITY DECREASED 3087 0.0429
121 WHEEZING 2542 0.0428
122 C-REACTIVE PROTEIN INCREASED 1522 0.0418
123 TREATMENT FAILURE 3464 0.0418
124 LIVER FUNCTION TEST INCREASED 882 0.0410
125 DRUG TOLERANCE 207 0.0409
126 INJURY 2872 0.0408
127 BLOODY DISCHARGE 46 0.0402
128 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 733 0.0400
129 MUSCULOSKELETAL STIFFNESS 3498 0.0399
130 DEAFNESS TRANSITORY 34 0.0398
131 GASTROINTESTINAL EROSION 25 0.0393
132 HEPATIC CIRRHOSIS 734 0.0390
133 EXPOSURE DURING PREGNANCY 2381 0.0383
134 MEAN PLATELET VOLUME DECREASED 32 0.0381
135 ILL-DEFINED DISORDER 2279 0.0375
136 TASTE DISORDER 760 0.0374
137 INFLAMMATION 1922 0.0372
138 ROAD TRAFFIC ACCIDENT 1542 0.0368
139 ABDOMINAL DISCOMFORT 6154 0.0367
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 625 0.0364
141 NORMAL NEWBORN 196 0.0360
142 SPINAL FUSION SURGERY 146 0.0360
143 IMMUNODEFICIENCY 536 0.0359
144 RASH VESICULAR 170 0.0351
145 ADVERSE REACTION 462 0.0348
146 VASCULAR ACCESS COMPLICATION 28 0.0346
147 LUNG DISORDER 1686 0.0344
148 OEDEMA 1861 0.0343
149 GENERAL PHYSICAL HEALTH DETERIORATION 3916 0.0338
150 MUSCULOSKELETAL PAIN 1721 0.0328
151 LIVER DISORDER 1397 0.0315
152 DELIRIUM 1078 0.0310
153 SLEEP DISORDER 2190 0.0310
154 INTENTIONAL PRODUCT USE ISSUE 2674 0.0305
155 GASTRIC ULCER PERFORATION 38 0.0300
156 ALOPECIA 5890 0.0300
157 GASTROINTESTINAL DISORDER 2648 0.0295
158 PRODUCT USED FOR UNKNOWN INDICATION 37 0.0294
159 RHEUMATOID LUNG 28 0.0293
160 PREGNANCY 576 0.0287
161 DRUG-INDUCED LIVER INJURY 902 0.0287
162 EPILEPSY 854 0.0279
163 JOINT STIFFNESS 724 0.0276
164 POLYARTHRITIS 144 0.0273
165 HYPERSENSITIVITY 4992 0.0269
166 DRY MOUTH 2046 0.0252
167 CONTUSION 2407 0.0250
168 THERAPY NON-RESPONDER 1109 0.0246
169 SINUSITIS 2453 0.0239
170 EAR INFECTION 634 0.0238
171 MEAN CELL VOLUME DECREASED 35 0.0227
172 DISABILITY 448 0.0226
173 EAR PAIN 438 0.0225
174 HEPATITIS 572 0.0223
175 PRODUCT USE ISSUE 4200 0.0223
176 INFECTION 3148 0.0217
177 MYOSITIS 187 0.0208
178 GENERAL SYMPTOM 156 0.0208
179 INTERNATIONAL NORMALISED RATIO FLUCTUATION 43 0.0208
180 HYPOAESTHESIA 3099 0.0207
181 KOUNIS SYNDROME 47 0.0207
182 OSTEOPOROSIS 836 0.0203
183 DYSPEPSIA 1999 0.0203
184 ARTERIAL HAEMORRHAGE 23 0.0201
185 REFLUX GASTRITIS 24 0.0199
186 PERIPHERAL SWELLING 3020 0.0196
187 CONFUSIONAL STATE 3111 0.0192
188 SEROMA 24 0.0189
189 HYPERTENSION 3984 0.0188
190 UPPER RESPIRATORY TRACT INFECTION 852 0.0184
191 MIGRAINE 1736 0.0182
192 MEAN CELL HAEMOGLOBIN DECREASED 33 0.0180
193 NECK PAIN 990 0.0177
194 SACROILIITIS 33 0.0175
195 ANKYLOSING SPONDYLITIS 225 0.0171
196 SUSPECTED OFF LABEL USE 77 0.0170
197 NASOPHARYNGITIS 3134 0.0170
198 LARGE INTESTINAL ULCER 46 0.0169
199 DUODENAL ULCER 116 0.0164
200 ASTHMA 1845 0.0163
201 AMNESIA 1037 0.0159
202 GASTROOESOPHAGEAL REFLUX DISEASE 1274 0.0158
203 PEPTIC ULCER 52 0.0157
204 URTICARIA 2620 0.0156
205 INFLAMMATORY MARKER INCREASED 77 0.0155
206 FREQUENT BOWEL MOVEMENTS 416 0.0154
207 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 259 0.0152
208 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 715 0.0149
209 WEIGHT FLUCTUATION 154 0.0147
210 BACK DISORDER 238 0.0146
211 LYME DISEASE 48 0.0144
212 RASH 6245 0.0143
213 FIBROSIS 44 0.0143
214 WEIGHT INCREASED 3191 0.0142
215 RESPIRATORY DISORDER 426 0.0142
216 CONDITION AGGRAVATED 4312 0.0142
217 ADVERSE EVENT 1267 0.0137
218 MUSCULAR WEAKNESS 1541 0.0135
219 MEMORY IMPAIRMENT 1819 0.0132
220 LIPOMA 34 0.0131
221 SPINAL STENOSIS 54 0.0131
222 MEDICATION ERROR 721 0.0130
223 VITAMIN B12 DECREASED 37 0.0128
224 PAIN 7588 0.0123
225 FOOT OPERATION 61 0.0123
226 JOINT ARTHROPLASTY 22 0.0123
227 ARTHRITIS 965 0.0123
228 ABDOMINAL PAIN UPPER 2516 0.0122
229 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 868 0.0122
230 ADVERSE DRUG REACTION 1087 0.0121
231 IRON DEFICIENCY 54 0.0120
232 ARTHRALGIA 4986 0.0120
233 CHRONIC GASTRITIS 27 0.0119
234 GASTRIC ULCER 227 0.0119
235 MELAENA 262 0.0119
236 FLUID RETENTION 605 0.0119
237 ADRENAL INSUFFICIENCY 140 0.0115
238 MUSCLE SPASTICITY 139 0.0113
239 DECREASED APPETITE 2620 0.0113
240 MICROCYTIC ANAEMIA 23 0.0110
241 SYNOVIAL CYST 51 0.0110
242 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
243 OEDEMA PERIPHERAL 1325 0.0109
244 PRODUCT USE IN UNAPPROVED INDICATION 2692 0.0109
245 DUODENAL ULCER HAEMORRHAGE 31 0.0108
246 GASTROINTESTINAL ULCER 24 0.0108
247 PARAESTHESIA 1699 0.0108
248 NEPHROGENIC ANAEMIA 50 0.0108
249 AORTIC ARTERIOSCLEROSIS 27 0.0105
250 CHEST PAIN 1924 0.0104
251 GASTRITIS EROSIVE 48 0.0103
252 GASTRIC PERFORATION 28 0.0103
253 MONOCYTE COUNT INCREASED 37 0.0102
254 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 27 0.0101
255 MUSCLE SPASMS 1841 0.0100
256 SHOULDER ARTHROPLASTY 27 0.0100
257 HYPERPARATHYROIDISM SECONDARY 25 0.0100
258 LUMBAR SPINAL STENOSIS 29 0.0099
259 DIVERTICULUM INTESTINAL 43 0.0098
260 DUODENITIS 30 0.0098
261 RASH ERYTHEMATOUS 465 0.0097
262 WHITE BLOOD CELL COUNT INCREASED 369 0.0096
263 UNDERDOSE 695 0.0095
264 ULCERATIVE KERATITIS 26 0.0095
265 INCORRECT PRODUCT ADMINISTRATION DURATION 205 0.0095
266 PYREXIA 3234 0.0093
267 RECTAL HAEMORRHAGE 401 0.0093
268 PLATELET COUNT INCREASED 121 0.0093
269 HYPERTRANSAMINASAEMIA 64 0.0092
270 FATIGUE 7159 0.0092
271 DECREASED IMMUNE RESPONSIVENESS 90 0.0092
272 JOINT EFFUSION 63 0.0091
273 GAIT DISTURBANCE 1743 0.0091
274 PAIN IN EXTREMITY 2644 0.0090
275 UPPER GASTROINTESTINAL HAEMORRHAGE 149 0.0088
276 PHYSICAL DISABILITY 39 0.0088
277 TENDERNESS 91 0.0087
278 OLIGOHYDRAMNIOS 29 0.0087
279 DEPRESSION 1977 0.0087
280 HEPATIC CYST 29 0.0085
281 TYPE I HYPERSENSITIVITY 30 0.0085
282 NECROTISING FASCIITIS 30 0.0085
283 INSOMNIA 2256 0.0085
284 MIGRAINE WITH AURA 23 0.0085
285 PRODUCT ADMINISTRATION INTERRUPTED 66 0.0084
286 TYPE IV HYPERSENSITIVITY REACTION 23 0.0084
287 PRE-EXISTING CONDITION IMPROVED 52 0.0083
288 FEELING HOT 509 0.0083
289 SEDATION 217 0.0083
290 PSORIASIS 1075 0.0082
291 KERATITIS 25 0.0082
292 MATERNAL EXPOSURE BEFORE PREGNANCY 55 0.0080
293 COLITIS ULCERATIVE 359 0.0080
294 ABDOMINAL DISTENSION 837 0.0080
295 LABORATORY TEST ABNORMAL 232 0.0079
296 ELECTRIC SHOCK SENSATION 22 0.0079
297 VOMITING 3681 0.0078
298 PRURITUS 2961 0.0077
299 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
300 WOUND DEHISCENCE 26 0.0077
301 INJECTION SITE REACTION 529 0.0077
302 SUDDEN CARDIAC DEATH 26 0.0076
303 REBOUND ACID HYPERSECRETION 23 0.0076
304 NODULE 99 0.0076
305 PNEUMONIA 2427 0.0075
306 CREPITATIONS 22 0.0074
307 THERAPEUTIC RESPONSE DECREASED 447 0.0074
308 IRON DEFICIENCY ANAEMIA 68 0.0074
309 GASTRIC ULCER HAEMORRHAGE 40 0.0072
310 TENDON DISORDER 47 0.0072
311 LARGE INTESTINE PERFORATION 50 0.0072
312 BRONCHITIS 532 0.0072
313 MALAISE 3146 0.0072
314 HEADACHE 4468 0.0071
315 ARTHRITIS BACTERIAL 29 0.0071
316 ABDOMINAL TENDERNESS 35 0.0070
317 HEPATIC PAIN 30 0.0070
318 VISUAL IMPAIRMENT 865 0.0070
319 HAEMATEMESIS 176 0.0069
320 ESCHERICHIA INFECTION 56 0.0068
321 TRICUSPID VALVE INCOMPETENCE 54 0.0068
322 OFF LABEL USE 5930 0.0068
323 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
324 PANCREATITIS 357 0.0067
325 NIGHTMARE 230 0.0066
326 ASTHENIA 2494 0.0066
327 OLIGURIA 41 0.0066
328 INTENTIONAL PRODUCT MISUSE 578 0.0066
329 TOXIC EPIDERMAL NECROLYSIS 100 0.0066
330 NEONATAL RESPIRATORY DISTRESS SYNDROME 23 0.0065
331 SPINAL OSTEOARTHRITIS 57 0.0065
332 FAECALOMA 35 0.0064
333 ABDOMINAL PAIN 1485 0.0064
334 PARANASAL SINUS DISCOMFORT 24 0.0063
335 BODY TEMPERATURE INCREASED 129 0.0063
336 BLOOD UREA INCREASED 105 0.0063
337 DIZZINESS 3114 0.0062
338 TACHYCARDIA 552 0.0062
339 HYPERHIDROSIS 794 0.0062
340 SEASONAL ALLERGY 87 0.0061
341 OVERWEIGHT 33 0.0061
342 GASTROENTERITIS VIRAL 109 0.0060
343 ANAPHYLACTIC REACTION 330 0.0060
344 PERIORBITAL OEDEMA 31 0.0060
345 DRUG INEFFECTIVE 7845 0.0059
346 DYSPNOEA 3364 0.0059
347 POSTOPERATIVE WOUND INFECTION 40 0.0059
348 DIABETIC NEUROPATHY 29 0.0059
349 RENAL FAILURE ACUTE 248 0.0058
350 NEPHROLITHIASIS 267 0.0058
351 HUMERUS FRACTURE 28 0.0058
352 DRUG EFFECT LESS THAN EXPECTED 86 0.0058
353 SKIN NECROSIS 30 0.0058
354 PRODUCT PHYSICAL CONSISTENCY ISSUE 32 0.0058
355 DYSLIPIDAEMIA 29 0.0057
356 PRODUCT QUALITY ISSUE 770 0.0057
357 GASTRIC HAEMORRHAGE 65 0.0056
358 WHEELCHAIR USER 25 0.0056
359 MOVEMENT DISORDER 180 0.0056
360 ANXIETY 1590 0.0056
361 ABNORMAL LOSS OF WEIGHT 38 0.0056
362 MUSCULOSKELETAL CHEST PAIN 86 0.0056
363 THROMBOCYTOPENIA 621 0.0055
364 GASTROINTESTINAL PAIN 61 0.0055
365 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 162 0.0055
366 SECRETION DISCHARGE 69 0.0055
367 SPINAL COLUMN STENOSIS 26 0.0055
368 SPINAL DISORDER 52 0.0055
369 PANCREATIC DISORDER 27 0.0055
370 PHLEBITIS 28 0.0055
371 DIARRHOEA 3528 0.0055
372 RHINITIS ALLERGIC 24 0.0054
373 HEAD DISCOMFORT 95 0.0054
374 BACK PAIN 1243 0.0053
375 WEIGHT DECREASED 1489 0.0053
376 DERMATITIS ALLERGIC 67 0.0053
377 APPLICATION SITE RASH 73 0.0053
378 RENAL TUBULAR NECROSIS 52 0.0053
379 IMMUNE THROMBOCYTOPENIA 24 0.0052
380 PHARYNGITIS 65 0.0052
381 COMPRESSION FRACTURE 28 0.0052
382 SPINAL PAIN 60 0.0051
383 ASPIRATION 56 0.0051
384 BREAST CANCER STAGE I 47 0.0051
385 MULTIPLE DRUG OVERDOSE 25 0.0050
386 RENAL CYST 40 0.0050
387 HIATUS HERNIA 65 0.0050
388 HYPOCALCAEMIA 95 0.0050
389 LUMBAR VERTEBRAL FRACTURE 23 0.0050
390 FOETAL EXPOSURE DURING PREGNANCY 407 0.0050
391 LOWER GASTROINTESTINAL HAEMORRHAGE 37 0.0050
392 ANURIA 43 0.0050
393 GUILLAIN-BARRE SYNDROME 24 0.0050
394 RENAL FUNCTION TEST ABNORMAL 23 0.0049
395 DEFORMITY 46 0.0049
396 GROIN PAIN 43 0.0049
397 NERVE COMPRESSION 45 0.0049
398 SLEEP APNOEA SYNDROME 93 0.0049
399 INTERVERTEBRAL DISC DEGENERATION 45 0.0049
400 PURPURA 43 0.0049
401 NAUSEA 3841 0.0048
402 VITAMIN D DEFICIENCY 47 0.0048
403 PHARYNGEAL SWELLING 47 0.0048
404 ENDOPHTHALMITIS 28 0.0047
405 HYPOKALAEMIA 215 0.0047
406 MUSCULOSKELETAL DISCOMFORT 80 0.0046
407 HAEMODIALYSIS 39 0.0046
408 LEUKOCYTOSIS 84 0.0046
409 ANAPHYLACTIC SHOCK 119 0.0046
410 LIMB DISCOMFORT 142 0.0046
411 URINE OUTPUT DECREASED 40 0.0046
412 MATERNAL DRUGS AFFECTING FOETUS 35 0.0046
413 BLOOD ALBUMIN DECREASED 36 0.0045
414 CHRONIC KIDNEY DISEASE 344 0.0045
415 ENTEROCOLITIS 26 0.0045
416 PRODUCT DELIVERY MECHANISM ISSUE 24 0.0045
417 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
418 END STAGE RENAL DISEASE 81 0.0044
419 FAECES DISCOLOURED 96 0.0044
420 APLASTIC ANAEMIA 23 0.0044
421 MULTI-ORGAN FAILURE 76 0.0044
422 ANKLE FRACTURE 68 0.0044
423 GASTROINTESTINAL HAEMORRHAGE 367 0.0044
424 ECCHYMOSIS 30 0.0044
425 SKIN LESION 119 0.0043
426 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
427 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
428 NEURALGIA 105 0.0043
429 NECROSIS 24 0.0043
430 INFUSION SITE SWELLING 27 0.0043
431 RASH PRURITIC 231 0.0043
432 MITRAL VALVE INCOMPETENCE 48 0.0042
433 SPINAL COMPRESSION FRACTURE 35 0.0042
434 ARTERIOSCLEROSIS CORONARY ARTERY 28 0.0042
435 FOOT FRACTURE 80 0.0042
436 HYPERKALAEMIA 147 0.0042
437 BLOOD URIC ACID INCREASED 24 0.0042
438 CONCUSSION 32 0.0041
439 FALL 1360 0.0041
440 HAEMATOCRIT DECREASED 81 0.0041
441 HEPATIC STEATOSIS 76 0.0041
442 PREMATURE LABOUR 23 0.0041
443 IMPAIRED GASTRIC EMPTYING 55 0.0040
444 INFUSION SITE ERYTHEMA 34 0.0040
445 RESPIRATORY TRACT INFECTION 105 0.0040
446 BLOOD ALKALINE PHOSPHATASE INCREASED 100 0.0040
447 TOOTH ABSCESS 41 0.0040
448 INTERVERTEBRAL DISC PROTRUSION 88 0.0040
449 HYPERAESTHESIA 33 0.0040
450 APPLICATION SITE VESICLES 26 0.0040
451 LEUKOPENIA 199 0.0040
452 DISSEMINATED INTRAVASCULAR COAGULATION 56 0.0040
453 TACHYPNOEA 54 0.0040
454 ULCER 63 0.0040
455 PULMONARY CONGESTION 52 0.0039
456 RESPIRATORY RATE INCREASED 35 0.0039
457 PERITONITIS 81 0.0039
458 OSTEOPENIA 59 0.0039
459 CIRCULATORY COLLAPSE 66 0.0039
460 SCOLIOSIS 24 0.0039
461 LIMB INJURY 105 0.0039
462 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 212 0.0039
463 NEPHROPATHY 36 0.0039
464 COLITIS ISCHAEMIC 26 0.0039
465 SKIN HAEMORRHAGE 57 0.0038
466 PROTHROMBIN TIME PROLONGED 23 0.0038
467 JOINT INJURY 82 0.0038
468 NASAL DRYNESS 24 0.0038
469 BLOOD SODIUM DECREASED 72 0.0038
470 SHOCK HAEMORRHAGIC 31 0.0038
471 GASTRITIS 100 0.0038
472 DIVERTICULUM 27 0.0038
473 FEEDING DISORDER 77 0.0038
474 BLOOD LACTATE DEHYDROGENASE INCREASED 60 0.0038
475 CHOLECYSTITIS 45 0.0038
476 DERMATITIS CONTACT 43 0.0038
477 UVEITIS 51 0.0038
478 ERYTHEMA MULTIFORME 35 0.0037
479 GAMMA-GLUTAMYLTRANSFERASE INCREASED 83 0.0037
480 ROTATOR CUFF SYNDROME 48 0.0037
481 STAPHYLOCOCCAL INFECTION 123 0.0037
482 ATELECTASIS 36 0.0037
483 DRUG ERUPTION 66 0.0037
484 EYE PAIN 210 0.0037
485 POST PROCEDURAL INFECTION 30 0.0037
486 PAIN IN JAW 104 0.0037
487 DYSSTASIA 107 0.0037
488 NEPHROTIC SYNDROME 25 0.0036
489 CARPAL TUNNEL SYNDROME 51 0.0036
490 APPLICATION SITE PAIN 80 0.0036
491 ANGIOEDEMA 160 0.0036
492 MOUTH ULCERATION 76 0.0036
493 INFUSION SITE PAIN 46 0.0036
494 EATING DISORDER 76 0.0036
495 PERIPHERAL COLDNESS 49 0.0036
496 SNEEZING 80 0.0036
497 LIGAMENT SPRAIN 35 0.0035
498 FLANK PAIN 33 0.0035
499 RETCHING 75 0.0035
500 ARTERIOSCLEROSIS 33 0.0035
501 HAEMOGLOBIN DECREASED 360 0.0035
502 GASTROENTERITIS 51 0.0035
503 BLOOD MAGNESIUM DECREASED 30 0.0035
504 FACIAL PAIN 31 0.0035
505 OVERDOSE 748 0.0035
506 AFFECTIVE DISORDER 27 0.0034
507 MYOCARDIAL ISCHAEMIA 39 0.0034
508 DRUG INTERACTION 542 0.0034
509 INITIAL INSOMNIA 35 0.0034
510 RED BLOOD CELL COUNT DECREASED 97 0.0034
511 JAUNDICE 91 0.0034
512 SENSORY DISTURBANCE 54 0.0034
513 HYPERLIPIDAEMIA 40 0.0033
514 SKIN REACTION 47 0.0033
515 BLOOD PRESSURE SYSTOLIC INCREASED 65 0.0033
516 MICTURITION URGENCY 38 0.0033
517 VISUAL FIELD DEFECT 24 0.0033
518 OSTEOMYELITIS 60 0.0033
519 DECUBITUS ULCER 27 0.0033
520 POLYURIA 27 0.0033
521 METABOLIC ACIDOSIS 105 0.0033
522 POST-TRAUMATIC STRESS DISORDER 22 0.0033
523 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
524 SWOLLEN TONGUE 102 0.0033
525 PULMONARY HYPERTENSION 68 0.0033
526 RESTLESS LEGS SYNDROME 59 0.0032
527 THERMAL BURN 23 0.0032
528 SEPTIC SHOCK 141 0.0032
529 TENDON RUPTURE 40 0.0032
530 STEVENS-JOHNSON SYNDROME 72 0.0032
531 ECONOMIC PROBLEM 49 0.0032
532 HYPOALBUMINAEMIA 25 0.0032
533 HEPATIC FUNCTION ABNORMAL 120 0.0032
534 SUDDEN DEATH 34 0.0032
535 PHOTOPHOBIA 60 0.0032
536 ANOREXIA 41 0.0032
537 TOOTH FRACTURE 35 0.0032
538 CHOLELITHIASIS 104 0.0032
539 FAECES SOFT 23 0.0032
540 FACE OEDEMA 53 0.0031
541 CORONARY ARTERY DISEASE 95 0.0031
542 SHOCK 72 0.0031
543 HAEMARTHROSIS 28 0.0031
544 URINARY RETENTION 104 0.0031
545 DIARRHOEA HAEMORRHAGIC 29 0.0031
546 ACUTE KIDNEY INJURY 473 0.0031
547 BODY HEIGHT DECREASED 33 0.0031
548 BRONCHOSPASM 44 0.0031
549 LOSS OF CONSCIOUSNESS 394 0.0031
550 BLOOD CREATININE INCREASED 200 0.0031
551 MULTIPLE ALLERGIES 24 0.0031
552 UPPER-AIRWAY COUGH SYNDROME 25 0.0030
553 BLOOD IRON DECREASED 36 0.0030
554 RIB FRACTURE 62 0.0030
555 ERYTHEMA 619 0.0030
556 BRAIN FOG 47 0.0030
557 BLOOD PRESSURE DIASTOLIC DECREASED 22 0.0030
558 ORAL CANDIDIASIS 39 0.0030
559 BLOOD URINE PRESENT 56 0.0029
560 SKIN INFECTION 33 0.0029
561 INCONTINENCE 31 0.0029
562 ELECTROCARDIOGRAM ABNORMAL 23 0.0029
563 PLEURAL EFFUSION 178 0.0029
564 BLOOD POTASSIUM INCREASED 47 0.0029
565 ERUCTATION 56 0.0029
566 DEAFNESS 75 0.0029
567 PRODUCT ODOUR ABNORMAL 30 0.0029
568 RENAL IMPAIRMENT 240 0.0029
569 KIDNEY INFECTION 56 0.0029
570 IMPAIRED WORK ABILITY 61 0.0029
571 LOCALISED INFECTION 69 0.0029
572 TREATMENT NONCOMPLIANCE 156 0.0028
573 MIDDLE INSOMNIA 53 0.0028
574 OESOPHAGITIS 31 0.0028
575 MUSCULOSKELETAL DISORDER 54 0.0028
576 NEUTROPHIL COUNT INCREASED 29 0.0028
577 PRODUCTIVE COUGH 135 0.0028
578 GENERALISED OEDEMA 35 0.0028
579 LIP SWELLING 94 0.0028
580 CONSTIPATION 615 0.0028
581 RENAL FAILURE 374 0.0028
582 DYSPNOEA EXERTIONAL 106 0.0028
583 METASTASES TO BONE 46 0.0028
584 BONE DISORDER 51 0.0028
585 GASTROINTESTINAL INFECTION 25 0.0028
586 ASPARTATE AMINOTRANSFERASE INCREASED 148 0.0028
587 PROSTATIC SPECIFIC ANTIGEN INCREASED 38 0.0028
588 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
589 SKIN ULCER 71 0.0027
590 ATRIAL SEPTAL DEFECT 23 0.0027
591 HAEMATOCHEZIA 151 0.0027
592 HYPONATRAEMIA 154 0.0027
593 SPLENOMEGALY 32 0.0027
594 GASTRIC DISORDER 93 0.0027
595 ACUTE HEPATIC FAILURE 37 0.0027
596 TRANSIENT ISCHAEMIC ATTACK 91 0.0027
597 VENTRICULAR EXTRASYSTOLES 28 0.0027
598 RENAL INJURY 80 0.0027
599 SKIN LACERATION 29 0.0027
600 SINUS CONGESTION 36 0.0027
601 BLOOD PRESSURE DECREASED 177 0.0027
602 HYPOPHAGIA 68 0.0027
603 CHROMATURIA 60 0.0027
604 ILEUS 33 0.0027
605 PALLOR 72 0.0026
606 HEPATOMEGALY 26 0.0026
607 RENAL PAIN 28 0.0026
608 RASH PAPULAR 59 0.0026
609 SCAB 30 0.0026
610 SCAR 45 0.0026
611 DYSURIA 96 0.0026
612 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 470 0.0026
613 CYSTITIS 83 0.0026
614 ALANINE AMINOTRANSFERASE INCREASED 160 0.0026
615 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
616 ILLNESS 268 0.0026
617 POOR QUALITY SLEEP 56 0.0026
618 HOSPITALISATION 398 0.0026
619 DRUG EXPOSURE DURING PREGNANCY 88 0.0026
620 NEPHROPATHY TOXIC 29 0.0026
621 BIPOLAR DISORDER 28 0.0026
622 DRUG TOXICITY 35 0.0026
623 GOUT 46 0.0026
624 DRY THROAT 26 0.0026
625 NOCTURIA 31 0.0026
626 CARDIAC MURMUR 22 0.0025
627 BODY TEMPERATURE DECREASED 25 0.0025
628 NASAL CONGESTION 149 0.0025
629 QUALITY OF LIFE DECREASED 34 0.0025
630 ABDOMINAL PAIN LOWER 64 0.0025
631 DISORIENTATION 100 0.0025
632 COAGULOPATHY 42 0.0025
633 TEMPERATURE INTOLERANCE 26 0.0025
634 BLOOD PRESSURE INCREASED 385 0.0025
635 CHEST DISCOMFORT 257 0.0025
636 MASS 35 0.0025
637 POST PROCEDURAL COMPLICATION 48 0.0025
638 BLOOD POTASSIUM DECREASED 75 0.0025
639 TINNITUS 114 0.0025
640 CYANOSIS 39 0.0025
641 EMPHYSEMA 25 0.0025
642 DIZZINESS POSTURAL 24 0.0025
643 DIPLOPIA 64 0.0025
644 ANAEMIA 466 0.0024
645 BLOOD BILIRUBIN INCREASED 66 0.0024
646 DENTAL CARIES 27 0.0024
647 COLD SWEAT 43 0.0024
648 POOR VENOUS ACCESS 25 0.0024
649 PNEUMONIA BACTERIAL 22 0.0024
650 PETECHIAE 25 0.0024
651 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 485 0.0024
652 HYPOXIA 84 0.0024
653 EXPIRED PRODUCT ADMINISTERED 79 0.0024
654 INTERSTITIAL LUNG DISEASE 115 0.0024
655 CELLULITIS 119 0.0024
656 ANHEDONIA 62 0.0024
657 TOOTH INFECTION 31 0.0023
658 MYOCLONUS 28 0.0023
659 BURNING SENSATION 164 0.0023
660 EAR DISCOMFORT 24 0.0023
661 HYPOTENSION 469 0.0023
662 CYST 29 0.0023
663 SKIN DISCOLOURATION 107 0.0023
664 SINUS TACHYCARDIA 33 0.0023
665 HYPOAESTHESIA ORAL 35 0.0023
666 VASCULITIS 27 0.0023
667 DECREASED ACTIVITY 25 0.0023
668 SUICIDE ATTEMPT 140 0.0023
669 SPINAL FRACTURE 46 0.0023
670 PARAESTHESIA ORAL 33 0.0023
671 HERPES ZOSTER 131 0.0023
672 SKIN DISORDER 76 0.0023
673 PNEUMONITIS 62 0.0023
674 CHOLECYSTECTOMY 26 0.0023
675 LYMPHOCYTE COUNT DECREASED 40 0.0023
676 LYMPHADENOPATHY 80 0.0023
677 HAEMOPTYSIS 63 0.0023
678 NERVE INJURY 25 0.0022
679 SEROTONIN SYNDROME 43 0.0022
680 URINARY TRACT INFECTION 381 0.0022
681 CARDIOGENIC SHOCK 32 0.0022
682 INTESTINAL PERFORATION 25 0.0022
683 PRODUCT ADMINISTRATION ERROR 45 0.0022
684 COORDINATION ABNORMAL 31 0.0022
685 SINUS DISORDER 44 0.0022
686 PRURITUS GENERALISED 48 0.0022
687 OROPHARYNGEAL PAIN 205 0.0022
688 SWELLING FACE 144 0.0022
689 CEREBRAL INFARCTION 54 0.0022
690 RHABDOMYOLYSIS 92 0.0022
691 RASH MACULO-PAPULAR 49 0.0022
692 CARDIOMEGALY 27 0.0022
693 URINARY INCONTINENCE 65 0.0022
694 HYPOTHYROIDISM 70 0.0022
695 SOPOR 29 0.0022
696 MYDRIASIS 28 0.0022
697 VERTIGO 133 0.0022
698 DRUG LEVEL INCREASED 36 0.0022
699 APPLICATION SITE ERYTHEMA 57 0.0022
700 LETHARGY 125 0.0022
701 ACUTE MYOCARDIAL INFARCTION 64 0.0022
702 TOOTH EXTRACTION 27 0.0022
703 SURGERY 127 0.0022
704 PARALYSIS 31 0.0022
705 LACTIC ACIDOSIS 70 0.0022
706 APPLICATION SITE PRURITUS 49 0.0022
707 PRODUCT USE COMPLAINT 34 0.0022
708 PROTEINURIA 41 0.0022
709 RHINORRHOEA 139 0.0021
710 BRAIN OEDEMA 27 0.0021
711 BLOOD CALCIUM DECREASED 24 0.0021
712 TENDONITIS 33 0.0021
713 MUSCLE ATROPHY 27 0.0021
714 ABSCESS 34 0.0021
715 DEHYDRATION 284 0.0021
716 APATHY 31 0.0021
717 MYALGIA 361 0.0021
718 INTESTINAL OBSTRUCTION 80 0.0021
719 OXYGEN SATURATION DECREASED 119 0.0021
720 SMALL INTESTINAL OBSTRUCTION 26 0.0021
721 OCULAR HYPERAEMIA 100 0.0021
722 INTENTIONAL OVERDOSE 135 0.0021
723 CONJUNCTIVITIS 39 0.0021
724 PRODUCT PRESCRIBING ERROR 50 0.0021
725 EYE SWELLING 78 0.0021
726 PRODUCT COMPLAINT 53 0.0021
727 CARDIOVASCULAR DISORDER 53 0.0021
728 DIABETES MELLITUS 159 0.0021
729 COLITIS 79 0.0021
730 SOMNOLENCE 419 0.0021
731 MYELODYSPLASTIC SYNDROME 30 0.0021
732 INTERNATIONAL NORMALISED RATIO INCREASED 59 0.0021
733 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
734 CAESAREAN SECTION 24 0.0021
735 ACCIDENTAL OVERDOSE 75 0.0020
736 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
737 TOOTHACHE 37 0.0020
738 INTENTIONAL DOSE OMISSION 58 0.0020
739 FEMUR FRACTURE 63 0.0020
740 LIVER FUNCTION TEST ABNORMAL 59 0.0020
741 ACUTE RESPIRATORY FAILURE 39 0.0020
742 INSURANCE ISSUE 31 0.0020
743 HEAD INJURY 64 0.0020
744 BACTERAEMIA 24 0.0020
745 DIVERTICULITIS 56 0.0020
746 PHARYNGEAL OEDEMA 31 0.0020
747 HAEMATURIA 69 0.0020
748 SYNCOPE 201 0.0020
749 UPPER LIMB FRACTURE 40 0.0020
750 BRADYCARDIA 106 0.0020
751 PALPITATIONS 234 0.0020
752 EYE IRRITATION 115 0.0020
753 HEART RATE IRREGULAR 45 0.0020
754 AGRANULOCYTOSIS 37 0.0020
755 BALANCE DISORDER 172 0.0020
756 DRY EYE 99 0.0020
757 BACTERIAL INFECTION 37 0.0020
758 FUNGAL INFECTION 66 0.0020
759 TOOTH DISORDER 44 0.0020
760 BEDRIDDEN 26 0.0020
761 RESPIRATORY TRACT CONGESTION 31 0.0019
762 HAEMORRHOIDS 38 0.0019
763 PERICARDIAL EFFUSION 45 0.0019
764 BLOOD CREATINE PHOSPHOKINASE INCREASED 56 0.0019
765 DYSARTHRIA 73 0.0019
766 SEPSIS 216 0.0019
767 HYPOKINESIA 28 0.0019
768 ORAL PAIN 43 0.0019
769 CATARACT 114 0.0019
770 MUSCLE TWITCHING 44 0.0019
771 TRANSAMINASES INCREASED 42 0.0019
772 NO THERAPEUTIC RESPONSE 23 0.0019
773 THROAT TIGHTNESS 51 0.0019
774 RESPIRATORY DEPRESSION 23 0.0019
775 SPINAL OPERATION 23 0.0019
776 RESPIRATORY FAILURE 136 0.0019
777 BONE PAIN 109 0.0019
778 BASAL CELL CARCINOMA 29 0.0019
779 LACRIMATION INCREASED 56 0.0019
780 ANGINA PECTORIS 53 0.0018
781 HYPERSOMNIA 53 0.0018
782 VISION BLURRED 253 0.0018
783 SKIN FISSURES 36 0.0018
784 INFLUENZA 205 0.0018
785 POLYNEUROPATHY 22 0.0018
786 DIALYSIS 26 0.0018
787 PREMATURE BABY 55 0.0018
788 HEART RATE DECREASED 64 0.0018
789 HEART RATE INCREASED 180 0.0018
790 VIRAL INFECTION 60 0.0018
791 ORAL HERPES 35 0.0018
792 ENCEPHALOPATHY 44 0.0018
793 COUGH 502 0.0018
794 DEVICE MALFUNCTION 125 0.0018
795 HEMIPARESIS 30 0.0018
796 DYSPHAGIA 168 0.0018
797 PRESYNCOPE 43 0.0018
798 GLAUCOMA 34 0.0018
799 MULTIPLE FRACTURES 29 0.0018
800 PNEUMONIA ASPIRATION 44 0.0018
801 RENAL DISORDER 82 0.0018
802 NEUROPATHY PERIPHERAL 167 0.0018
803 APHASIA 53 0.0018
804 DEEP VEIN THROMBOSIS 114 0.0018
805 PULMONARY MASS 26 0.0017
806 PANCREATITIS ACUTE 39 0.0017
807 ORTHOSTATIC HYPOTENSION 30 0.0017
808 THERAPEUTIC RESPONSE SHORTENED 57 0.0017
809 DERMATITIS 36 0.0017
810 CHILLS 201 0.0017
811 ERECTILE DYSFUNCTION 44 0.0017
812 EYE DISORDER 56 0.0017
813 PNEUMOTHORAX 27 0.0017
814 HALLUCINATION, AUDITORY 27 0.0017
815 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
816 FEELING ABNORMAL 403 0.0017
817 FEELING JITTERY 32 0.0017
818 POLLAKIURIA 70 0.0017
819 DELUSION 26 0.0017
820 LUNG INFECTION 26 0.0017
821 HOT FLUSH 126 0.0017
822 DISTURBANCE IN ATTENTION 90 0.0017
823 RESTLESSNESS 61 0.0017
824 HEPATOTOXICITY 37 0.0017
825 HAEMATOMA 43 0.0017
826 COVID-19 291 0.0017
827 HYPERTHYROIDISM 24 0.0017
828 CARDIAC FAILURE 133 0.0017
829 EOSINOPHILIA 29 0.0017
830 PRODUCT DOSE OMISSION ISSUE 486 0.0017
831 WHITE BLOOD CELL COUNT DECREASED 179 0.0016
832 PELVIC PAIN 30 0.0016
833 MENTAL IMPAIRMENT 40 0.0016
834 EYE HAEMORRHAGE 22 0.0016
835 MUCOSAL INFLAMMATION 43 0.0016
836 SPEECH DISORDER 86 0.0016
837 DISEASE RECURRENCE 78 0.0016
838 RESPIRATORY ARREST 45 0.0016
839 RASH MACULAR 57 0.0016
840 PULMONARY OEDEMA 73 0.0016
841 THROAT IRRITATION 73 0.0016
842 ARRHYTHMIA 77 0.0016
843 HEPATIC FAILURE 49 0.0016
844 SKIN EXFOLIATION 137 0.0016
845 PANIC ATTACK 59 0.0016
846 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
847 HALLUCINATION, VISUAL 34 0.0016
848 PULMONARY EMBOLISM 153 0.0016
849 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 84 0.0016
850 FLATULENCE 91 0.0016
851 TREMOR 266 0.0016
852 ATRIAL FIBRILLATION 155 0.0016
853 DYSPHONIA 93 0.0016
854 CHOKING 31 0.0016
855 ORAL DISCOMFORT 22 0.0016
856 FEELING COLD 44 0.0016
857 NERVOUS SYSTEM DISORDER 49 0.0016
858 CONVULSION 89 0.0016
859 PRODUCT DOSE OMISSION IN ERROR 44 0.0016
860 MALIGNANT NEOPLASM PROGRESSION 158 0.0015
861 CANDIDA INFECTION 26 0.0015
862 FULL BLOOD COUNT DECREASED 31 0.0015
863 FRACTURE 29 0.0015
864 BONE DENSITY DECREASED 48 0.0015
865 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
866 HIP FRACTURE 49 0.0015
867 NEUTROPHIL COUNT DECREASED 62 0.0015
868 PHOTOSENSITIVITY REACTION 25 0.0015
869 EPISTAXIS 113 0.0015
870 BLOOD PRESSURE ABNORMAL 30 0.0015
871 RASH GENERALISED 39 0.0015
872 VISUAL ACUITY REDUCED 50 0.0015
873 HAEMORRHAGE 156 0.0015
874 INJECTION SITE WARMTH 30 0.0015
875 DYSKINESIA 59 0.0015
876 PRODUCT AVAILABILITY ISSUE 33 0.0014
877 HALLUCINATION 109 0.0014
878 EYE PRURITUS 48 0.0014
879 BLOOD PRESSURE FLUCTUATION 34 0.0014
880 ECZEMA 74 0.0014
881 ACUTE RESPIRATORY DISTRESS SYNDROME 25 0.0014
882 COGNITIVE DISORDER 66 0.0014
883 SUICIDAL IDEATION 129 0.0014
884 CHOLESTASIS 27 0.0014
885 CARDIAC ARREST 116 0.0014
886 THROMBOSIS 113 0.0014
887 MENTAL DISORDER 61 0.0014
888 IRRITABILITY 84 0.0014
889 PLATELET COUNT DECREASED 147 0.0014
890 ABASIA 34 0.0014
891 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
892 AGEUSIA 34 0.0014
893 HYPOGLYCAEMIA 66 0.0014
894 PANCYTOPENIA 76 0.0014
895 MUSCLE TIGHTNESS 22 0.0014
896 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
897 INCORRECT DOSE ADMINISTERED 306 0.0013
898 METASTASES TO LIVER 23 0.0013
899 HERNIA 25 0.0013
900 DRUG RESISTANCE 33 0.0013
901 UNEVALUABLE EVENT 97 0.0013
902 OSTEONECROSIS 42 0.0013
903 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
904 RESPIRATORY DISTRESS 35 0.0013
905 MOOD SWINGS 40 0.0013
906 FLUSHING 127 0.0012
907 MOOD ALTERED 34 0.0012
908 AGITATION 91 0.0012
909 WITHDRAWAL SYNDROME 52 0.0012
910 EXPOSURE VIA SKIN CONTACT 32 0.0012
911 HYPOACUSIS 53 0.0012
912 DEPRESSED MOOD 65 0.0012
913 DYSGEUSIA 90 0.0012
914 MYOCARDIAL INFARCTION 209 0.0012
915 INJECTION SITE BRUISING 95 0.0012
916 NO ADVERSE EVENT 215 0.0012
917 INFLUENZA LIKE ILLNESS 97 0.0012
918 UNRESPONSIVE TO STIMULI 30 0.0012
919 MENTAL STATUS CHANGES 32 0.0012
920 DISEASE PROGRESSION 135 0.0011
921 EMOTIONAL DISTRESS 138 0.0011
922 ASCITES 33 0.0011
923 PROCEDURAL PAIN 31 0.0011
924 CEREBRAL HAEMORRHAGE 40 0.0011
925 SKIN CANCER 24 0.0011
926 ELECTROCARDIOGRAM QT PROLONGED 40 0.0011
927 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
928 COMA 52 0.0011
929 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
930 BONE MARROW FAILURE 22 0.0011
931 PAIN OF SKIN 29 0.0011
932 SKIN IRRITATION 49 0.0011
933 NERVOUSNESS 55 0.0011
934 INJECTION SITE SWELLING 80 0.0010
935 TOXICITY TO VARIOUS AGENTS 176 0.0010
936 HYPERGLYCAEMIA 38 0.0010
937 SEIZURE 120 0.0010
938 MULTIPLE SCLEROSIS 49 0.0010
939 PSYCHOTIC DISORDER 30 0.0010
940 CARDIAC DISORDER 95 0.0010
941 BLINDNESS 41 0.0010
942 FEAR 27 0.0010
943 INJECTION SITE PRURITUS 67 0.0010
944 SKIN BURNING SENSATION 70 0.0010
945 INJECTION SITE ERYTHEMA 120 0.0010
946 NEEDLE ISSUE 28 0.0010
947 DRUG ABUSE 79 0.0009
948 INJECTION SITE MASS 35 0.0009
949 DRUG EFFECT INCOMPLETE 34 0.0009
950 DEMENTIA 26 0.0009
951 OSTEONECROSIS OF JAW 23 0.0009
952 ACCIDENTAL EXPOSURE TO PRODUCT 95 0.0009
953 NEOPLASM PROGRESSION 32 0.0009
954 ANGER 31 0.0009
955 EMOTIONAL DISORDER 28 0.0009
956 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 63 0.0009
957 CRYING 32 0.0009
958 CEREBROVASCULAR ACCIDENT 149 0.0009
959 ABNORMAL DREAMS 24 0.0009
960 DRY SKIN 113 0.0008
961 CARDIAC FAILURE CONGESTIVE 68 0.0008
962 VAGINAL HAEMORRHAGE 36 0.0008
963 PRODUCT SUBSTITUTION ISSUE 47 0.0008
964 CARDIO-RESPIRATORY ARREST 34 0.0008
965 INJECTION SITE PAIN 247 0.0008
966 THERAPY INTERRUPTED 57 0.0008
967 NEOPLASM MALIGNANT 53 0.0008
968 PRODUCT DOSE OMISSION 51 0.0008
969 AGGRESSION 39 0.0008
970 DEVICE LEAKAGE 33 0.0008
971 LUNG NEOPLASM MALIGNANT 31 0.0008
972 FEBRILE NEUTROPENIA 50 0.0008
973 BLOOD GLUCOSE INCREASED 142 0.0008
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 27 0.0007
975 DEVICE ISSUE 66 0.0007
976 DEATH 633 0.0007
977 DERMATITIS ATOPIC 38 0.0007
978 NEUTROPENIA 93 0.0007
979 INJECTION SITE HAEMORRHAGE 52 0.0007
980 DRUG EFFECT DECREASED 35 0.0006
981 MULTIPLE SCLEROSIS RELAPSE 44 0.0006
982 ABNORMAL BEHAVIOUR 25 0.0006
983 BLOOD GLUCOSE DECREASED 30 0.0006
984 ABORTION SPONTANEOUS 25 0.0006
985 BREAST CANCER 56 0.0006
986 PROSTATE CANCER 47 0.0006
987 COMPLETED SUICIDE 46 0.0006
988 DRUG WITHDRAWAL SYNDROME 45 0.0005
989 THERAPY CESSATION 23 0.0004
990 PRODUCT STORAGE ERROR 36 0.0004
991 DRUG DEPENDENCE 57 0.0004
992 DRUG DOSE OMISSION 54 0.0003
993 ACNE 24 0.0003